Integrated multi-omics analyses reveal Jorunnamycin A as a novel suppressor for muscle-invasive bladder cancer by targeting FASN and TOP1

Abstract Background Bladder cancer is a urological carcinoma with high incidence, among which muscle invasive bladder cancer (MIBC) is a malignant carcinoma with high mortality. There is an urgent need to develop new drugs with low toxicity and high efficiency for MIBC because existing medication ha...

Descripción completa

Detalles Bibliográficos

Autores principales:	Ruijiao Chen, Xiaopeng Hao, Jingyuan Chen, Changyue Zhang, Huixia Fan, Fuming Lian, Xiaochuan Chen, Chao Wang, Yong Xia
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	BMC 2023-08-01
Colección:	Journal of Translational Medicine
Materias:	Jorunnamycin A Muscle invasive bladder cancer Proteomics Transcriptomics Proliferation Apoptosis
Acceso en línea:	https://doi.org/10.1186/s12967-023-04400-3
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!